Reply to ‘Comment on ‘Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy’’

Reply to 'Comment on 'Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy''

British Journal of Cancer 116, e11 (11 April 2017). doi:10.1038/bjc.2017.61

Authors: Takeo Fujii & Naoto T Ueno

http://ift.tt/2mq9ep7